- Business Type:
- Manufacturer, Trading Company
- Year Established:
- 2015
- Total Revenue:
- US$50 Million - US$100 Million
- Main Products:
- Neomycin Sulfate Micronized, Neomycin Sulfate, Dihydrostreptomycin Sulfate, Streptomycin<br /> Sulfate Oral, Oxytetracycline Hydrochloride, Framycetin Sulfate, Gentamycin Sulfate,<br /> Rifapentine
Contacts
- Mr. Karl

